Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/05/2008CN101298613A Transforming growth factor alpha-HII
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101298479A Antibodies for inhibiting blood coagulation and methods of use thereof
11/05/2008CN101298478A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of hla
11/05/2008CN101297965A Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma
11/05/2008CN101297964A Preparation of chicken thymosin microsphere novel dosage form
11/05/2008CN101297963A Pharmaceutical composition of proinsulin C peptide
11/05/2008CN101297962A Preparation of pig interferon novel dosage form
11/05/2008CN101297961A Preparation of dog interferon novel dosage form
11/05/2008CN101297960A Preparation of chicken interferon novel dosage form
11/05/2008CN101297959A Preparation of chicken interleukin-2 microsphere novel dosage form
11/05/2008CN101297958A Medicament composition for preventing and treating colibacillosis of chicken
11/05/2008CN101297957A Non-covalent complex formed by glutathion and vitamin B group and uses thereof
11/05/2008CN101297673A Method for processing fish collagen oligopeptide
11/05/2008CN101297672A Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal
11/05/2008CN101297655A Compound formulation for killing bacillus spore
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430476C Tumor-lysing virus growing selectively in tumor cells
11/05/2008CN100430417C Transferin (Tf)- nerve growth factor (NGF) conjugate preparation method
11/05/2008CN100430416C New alpha - conantokins, coded polynucleotide and application
11/05/2008CN100430414C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C)
11/05/2008CN100430378C New piperidine derivative
11/05/2008CN100430090C A composition for the prevention and/or treatment of atherosclerosis
11/05/2008CN100430089C The use of melagatran for the manufacture of a medicament for the treatment of type I diabetes mellitus
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430061C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
11/04/2008US7447595 Heterologous protein production using the twin arginine translocation pathway
11/04/2008US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression
11/04/2008US7446185 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446181 Antibodies that bind human Dickkopf-1 proteins
11/04/2008US7446179 CD19-specific chimeric T cell receptor
11/04/2008US7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
11/04/2008US7446176 Of given amino acid sequence; bind to antibodies; detecting integrin; diagnosing and treating disorders
11/04/2008US7446174 Protein based TNF-α variants for the treatment of TNF-α related disorders
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446172 Cytokine protein family
11/04/2008US7446169 Human tumor necrosis factor receptor-like 2
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446120 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor
11/04/2008US7446102 Antibacterial amide macrocycles IV
11/04/2008US7446096 Glutathione based delivery system
11/04/2008US7446095 Peptides modulating caspase activation
11/04/2008US7446094 Cylcic peptide containing oxazole/thiazole/imidazole fragment and aminoacidic fragment; antitumor agents
11/04/2008US7446093 Administering cyclosporin and dimethyl sulfoxide sterile injectable solution by injection into a cerebrospinal fluid or cerebrospinal fluid spaces
11/04/2008US7446092 Glycogen synthase kinase-3 inhibitors
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7446090 FSH formulation
11/04/2008US7446089 such as lactoferrin, conalbumin; combinations with antibiotics, microbiocides for e.g. disinfecting, preserving food, treating infections; also chelating agents such as ,19,30-trioxa-1,4,10,13,16,22,27,33-octaazabicyclo(11,11,11)pentatriacontane hexahydrobromide
11/04/2008US7445930 Method for the production and purification of adenoviral vectors
11/04/2008US7445922 Enhance effects of an endoglucanase enzyme on fabric treatment such as reduction of fuzzing, improvement in feel and appearance, color clarification, partial color change, and softening of cellulose-containing fabrics
11/04/2008US7445919 Zsig33-like peptides and polynucleotides
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/04/2008US7445890 Screening for compound that inhibits uncoupling protein (Ucp) activity; measuring expression level of reporter molecule (luciferase) in transformant; drugs for obesity, diabetes, depression
11/04/2008US7445802 Conjugates of alliinase with a protein carrier that targets the alliinase to specific cells are used in combination with alliin to produce allicin at a desired target site to kill cancer cells or pathogens.
11/04/2008US7445788 Polypeptide for use in the diagnosis and detection of bacterial infections
11/04/2008US7445784 Apoptosis of rectum and prostate cancer
11/04/2008US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease
11/04/2008US7445779 Methods of modulating IFNy production
11/04/2008US7445778 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
11/04/2008US7445777 Enzymatic treatment of retinitis pigmentosis
11/04/2008US7445776 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
11/04/2008US7445775 Mammalian nucleotide sequence coding plasminogen catalytic domain and optionally kringle domains linked to promoter; ischemic stroke, arterial thrombotic diseases
11/04/2008US7445774 Glycosylated interferon α
11/04/2008US7445773 Polypeptide of given sequence which inhibits hepatitis virus replication; pegylated or recombinant; reduces viral infections and increases monocyte counts; stimulates hematopoietic cells
11/04/2008US7445772 Heterodimeric four helix bundle cytokines
11/04/2008US7445766 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture
11/04/2008US7445764 Carrier-drug conjugate
11/04/2008US7445641 Biomaterials modified with superoxide dismutase mimics
11/04/2008US7445629 Medical device for delivering biologically active material
11/04/2008CA2362481C Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/04/2008CA2325360C Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
11/04/2008CA2223432C Radiometal-binding analogues of luteinizing hormone releasing hormone
11/04/2008CA2183871C Platelet growth accelerator
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/04/2008CA2169834C Pharmaceutical formulations of nerve growth factor
11/04/2008CA2136870C Anti-aids immunomodulation complex
10/2008
10/30/2008WO2008131301A1 Surfaces, methods and devices employing cell rolling
10/30/2008WO2008131099A1 Biological agents active in central nervous system
10/30/2008WO2008131052A2 Novel peptide amphiphiles having improved solubility and methods of using same
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008130803A2 Pulmonary delivery of spherical insulin microparticles
10/30/2008WO2008130647A1 Copolymer synthesized from modified glycosaminoglycan, gag, and an anhydride functionalized hydrophobic polymer
10/30/2008WO2008130635A2 Formation of superfibronectin by bbk32 and uses therefor
10/30/2008WO2008130607A2 Wound healing compositions containing keratin biomaterials
10/30/2008WO2008130591A2 Using trefoil polypeptides to treat eye lesions associated with ophthalmic procedures
10/30/2008WO2008130464A1 Macrocyclic ghrelin receptor modulators and methods of using the same
10/30/2008WO2008130315A1 Method and product for treatment and/or prevention of complications of prematurity
10/30/2008WO2008130255A1 Glycated milk and uses thereof
10/30/2008WO2008130217A1 Cyclic angiotensin analogs
10/30/2008WO2008130066A1 Mono modified exendin with polyethylene glycol or its derivatives and uses thereof
10/30/2008WO2008129851A1 Nitric oxide synthase activator
10/30/2008WO2008129430A1 Method for vap preventative ventilation of intubated critically ill patients
10/30/2008WO2008129422A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008WO2008128342A1 Composition for enhancing bone formation
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008128329A1 Endotoxin removal
10/30/2008WO2008104062A3 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect
1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 3163